Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: innovative therapies for Central Nervous System

Newron Pharmaceuticals – innovative therapies for Central Nervous System

Posted on by

Newron Pharmaceuticals is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.

Newron Pharmaceuticals – innovative therapies for Central Nervous System

Newron Pharmaceuticals

Continue reading →

Posted in Biotech Companies, Biotech Companies Clinical Stage, Biotech Companies CNS Neuroscience, Biotech Companies Drug Development, Biotech Companies Europe, Biotech Companies Italy, Biotech Companies Parkinson’s disease, Biotech Companies Preclinical Stage, Biotech Companies Rett Syndrome, Biotech Companies Schizophrenia, Biotech Companies Sweden, Biotech Companies Switzerland, Biotech Companies Therapeutics | Tagged add-on therapy, central nervous system, CNS, innovative therapies Central Nervous System, innovative therapies for Central Nervous System, Newron, Newron Pharmaceuticals, Newron Pharmaceuticals - innovative therapies for Central Nervous System, NW-3509, NWRN, pain, Parkinson, ralfinamide, rare disease, Rett syndrome, safinamide, sarizotan, Schizophrenia

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress